















A New Dawn
Leading innovation in perfusion technology
Supporting some of America's most accomplished surgeons, physicians, and scientists by creating the ‘tools’ needed to perfuse and preserve a wide variety of organs and tissue ex vivo—out of the body—allowing them to advance drug and gene therapy research, technology that is now set to transform the world of organ transplant.
Experts in high control, low pressure, air, and fluid flow technology solutions, with one of our many patented technologies, emulating the “push and pull” of the cardiovascular system, providing the very ‘heart’ for a series of commercial products and newly emerging devices.
Our Management Team
Leading research and innovation expert in perfusion technology
Significant knowledge and network within the medical arena.
Led national and Federal award winning response to COVID-19 crisis
Wide range of leadership positions in the commercialization and development of drugs and devices. Notable career experiences include planning launches for novel devices and drugs, establishing research, development and commercial partnerships, and overseeing payor strategy and patient support services for a multi-billion-dollar product franchise. Co-invented and led the development of a diagnostic device now under ongoing approval by regulators around the globe.
Bachelor of Science in Chemical Engineering from Rice University and MBA from Columbia Business School.
2020, US Secretary of Defense awarded the Defense Meritorious Service Medal to Dr. Gerber for exceptionally meritorious service for the Armed Forces.
In 2010 David was appointed by the Secretary of the Department of Health and Human Services (HHS) to the Advisory Committee on Transplantation.
14 years from research and development of perfusion tech
Co-author of many peer reviewed publications and papers
Leading the BMI lab at Duke Hospital
30+ years of engineering experience from US security clearance systems
US veteran who has held security clearance
Worked on multiple groundbreaking medical advancement systems
Special Advisor on Capitol Hill
Government and key stakeholder relations specialist
Helped forge industry/academic partnerships and PPP’s
Mark helped forge BMI’s relationships with Dr. Prabir Roy-Chaudhury MD, Ph.D, FRCP, co-Director of the Kidney Center UNC Chapel Hill, and with Dr. Tony Atala, MD, founding Director of the Wake Forest Institute of Regenerative Medicine, and negotiated the establishment of a new Recove laboratory based at the WFIRM ReMDO RegeneratOR in Winston-Salem.
Medical & Scientific Advisory Board
Leads Duke Ex-Vivo Organ Laboratory (DEVOL), focused on laboratory development of novel strategies to enhance the function of high-risk transplanted organs.
Recipient of multiple national grant awards and cited in multiple peer review publications
Government and key stakeholder relations specialist
Helped forge industry/academic partnerships and PPP’s
2020, US Secretary of Defense awarded the Defense Meritorious Service Medal to Dr. Gerber for exceptionally meritorious service for the Armed Forces.
In 2010 David was appointed by the Secretary of the Department of Health and Human Services (HHS) to the Advisory Committee on Transplantation.
Founding co-Chair of the Kidney Health Initiative which is a public-private partnership between the American Society of Nephrology (ASN) and the FDA
Leads research programs funded by NIH, the VA and industry partners; has published over 175 papers; sought after speaker
Board-certified thoracic surgeon with Duke University Hospital
Leads national and international efforts to develop new treatments for patients with diseases within the chest
Recipient of many national grant awards and cited in multiple peer review publications
Editor-in-Chief for the journal Hepatic Medicine: Evidence and Research
Formerly Associate Professor of Medicine at Weill Cornell Medical Center and Center for the Study of Hepatitis C with Charles M. Rice (Nobel Laureate 2020), and
Associate Professor of Medicine at Harvard Medical School